Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BG-60366 |
Synonyms | |
Therapy Description |
BG-60366 is a chimeric degradation activation compound (CDAC) comprising a ligand that binds to E3 ubiquitin ligase linked to a ligand targeting mutant EGFR, which potentially induces proteasome-mediated degradation of mutant EGFR and decreased growth of tumor cells (NCI Drug Dictionary). |